1
|
Janot K, Charbonnier G, Marnat G, Sporns P, Burel J, Papagiannaki C, Forestier G, Hak JF, Agripnidis T, Bolognini F, Lebedinsky PA, Ifergan H, Bibi R, Herbreteau D, Adeniran Bankole ND, Biondi A, Barreau X, Guédon A, Shotar E, Clarençon F, Kerleroux B, Boulouis G, Bala F, Rouchaud A. Persistent flow inside the Woven EndoBridge at angiographic follow-up: A multicenter study. Interv Neuroradiol 2023:15910199231185805. [PMID: 37403459 DOI: 10.1177/15910199231185805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/06/2023] Open
Abstract
BACKGROUND The occurrence of persistent intra-device filling (BOSS 1, using the Bicêtre Occlusion Scale Score (BOSS)) in aneurysms treated with a Woven Endobridge (WEB) device is infrequent based on angiographic follow-up. To date, three monocentric case series were published studying BOSS 1 cases. Through a multicenter retrospective study, we aimed to report the incidence, and risk factors of intra-WEB persistent filling. METHODS We reached out to European academic centers that treat patients using WEB devices and requested de-identified data of patients treated with a WEB device and underwent angiographic follow-up, at least 3 months after embolization, to assess the BOSS 1 occlusion score. We compared baseline characteristics, treatment modalities, and aneurysm data of the included BOSS 1 patients with those of a control group consisting of non-BOSS 1 patients (n = 116) who had an available angiographic follow-up. Univariable and multivariable models were employed for analysis. RESULTS Among the pooled sample of 591 aneurysms treated with WEB, the rate of persistent flow (BOSS 1) at angiographic follow-up was 5.2% (n = 31 out of 591), performed after an average of 8.7 ± 6.3 months. In the multivariable-adjusted analysis, dual antiplatelet therapy in the postoperative period (adjusted odds ratio [aOR] 4.3 [95% CI 1.3-14.2]), and WEB undersizing (aOR 10.8 [95% CI 2.9-40]) were independently associated with a BOSS 1 persistent flow result. CONCLUSION Persistent blood flow within the WEB device during angiographic follow-up (BOSS 1) is an uncommon occurrence. Our findings indicate that post-procedural dual antiplatelet therapy and undersizing of the WEB device are independently associated with the presence of BOSS 1 at follow-up.
Collapse
Affiliation(s)
- Kevin Janot
- Interventional Neuroradiology Department, University Hospital of Tours, Tours, France
| | - Guillaume Charbonnier
- Interventional Neuroradiology Department, University Hospital of Besançon, Besançon, France
| | - Gaultier Marnat
- Diagnostic and Interventional Neuroradiology Department, University Hospital of Bordeaux, Bordeaux, France
| | - Peter Sporns
- Interventional Neuroradiology Department, University Hospital of Basel, Basel, Switzerland
- Interventional Neuroradiology Department, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
| | - Julien Burel
- Interventional Neuroradiology Department, University Hospital of Rouen, Rouen, France
| | | | - Geraud Forestier
- Interventional Neuroradiology Department, University Hospital of Limoges, Limoges, France
| | - Jean-Francois Hak
- Interventional Neuroradiology Department, University Hospital of Marseille, Marseille, France
| | - Thibault Agripnidis
- Interventional Neuroradiology Department, University Hospital of Marseille, Marseille, France
| | | | | | - Heloise Ifergan
- Interventional Neuroradiology Department, University Hospital of Tours, Tours, France
| | - Richard Bibi
- Interventional Neuroradiology Department, University Hospital of Tours, Tours, France
| | - Denis Herbreteau
- Interventional Neuroradiology Department, University Hospital of Tours, Tours, France
| | | | - Alessandra Biondi
- Interventional Neuroradiology Department, University Hospital of Besançon, Besançon, France
| | - Xavier Barreau
- Diagnostic and Interventional Neuroradiology Department, University Hospital of Bordeaux, Bordeaux, France
| | - Alexis Guédon
- Interventional Neuroradiology Department, Lariboisière Hospital, Paris, France
| | - Eimad Shotar
- Neuroradiology Department, Pitié Salpêtrière Hospital, Paris, France
| | | | - Basile Kerleroux
- Interventional Neuroradiology Department, Saint Anne Hospital, Paris, France
| | - Grégoire Boulouis
- Interventional Neuroradiology Department, University Hospital of Tours, Tours, France
| | - Fouzi Bala
- Interventional Neuroradiology Department, University Hospital of Tours, Tours, France
| | - Aymeric Rouchaud
- Interventional Neuroradiology Department, University Hospital of Limoges, Limoges, France
| |
Collapse
|
2
|
Pop R, Hasiu A, Bolognini F, Mihoc D, Quenardelle V, Gheoca R, Schluck E, Courtois S, Delaitre M, Musacchio M, Pottecher J, Chamaraux-Tran TN, Sellal F, Wolff V, Lebedinsky PA, Beaujeux R. Stroke Thrombectomy in Patients with COVID-19: Initial Experience in 13 Cases. AJNR Am J Neuroradiol 2020; 41:2012-2016. [PMID: 32816767 DOI: 10.3174/ajnr.a6750] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2020] [Accepted: 06/26/2020] [Indexed: 01/06/2023]
Abstract
We performed a retrospective review in both comprehensive stroke units of a region affected early by the coronavirus disease 2019 (COVID-19) pandemic, between March 1 and April 26, 2020, including patients with COVID-19 who underwent mechanical thrombectomy for ischemic stroke. We identified 13 cases, representing 38.2% of 34 thrombectomies performed during this period. We observed increased mortality and a high incidence of thrombotic complications during hospitalization. Given the high rate of infected patients, systematic use of full personal protection measures seems justified.
Collapse
Affiliation(s)
- R Pop
- From the Interventional Neuroradiology Department (R.P., A.H., D.M., R.B.) .,Institut de Chirurgie Minime Invasive Guidée par l'Image (R.P., R.B.), Strasbourg, France
| | - A Hasiu
- From the Interventional Neuroradiology Department (R.P., A.H., D.M., R.B.)
| | - F Bolognini
- Diagnostic and Interventional Neuroradiology Department (F.B., M.D., M.M., P.A.L.)
| | - D Mihoc
- From the Interventional Neuroradiology Department (R.P., A.H., D.M., R.B.)
| | | | | | - E Schluck
- Neurology Department (E.S., S.C.), Emile Muller Hospital, Mulhouse, France
| | - S Courtois
- Neurology Department (E.S., S.C.), Emile Muller Hospital, Mulhouse, France
| | - M Delaitre
- Diagnostic and Interventional Neuroradiology Department (F.B., M.D., M.M., P.A.L.)
| | - M Musacchio
- Diagnostic and Interventional Neuroradiology Department (F.B., M.D., M.M., P.A.L.)
| | - J Pottecher
- Department of Anesthesia (J.P., T.-N.C.-T.), Strasbourg University Hospitals, Strasbourg, France
| | - T-N Chamaraux-Tran
- Department of Anesthesia (J.P., T.-N.C.-T.), Strasbourg University Hospitals, Strasbourg, France
| | - F Sellal
- Neurology Department (F.S.), Hôpitaux Civils de Colmar, Colmar, France
| | - V Wolff
- Stroke Unit (V.Q., R.G., V.W.)
| | - P A Lebedinsky
- Diagnostic and Interventional Neuroradiology Department (F.B., M.D., M.M., P.A.L.)
| | - R Beaujeux
- From the Interventional Neuroradiology Department (R.P., A.H., D.M., R.B.).,Institut de Chirurgie Minime Invasive Guidée par l'Image (R.P., R.B.), Strasbourg, France
| |
Collapse
|